Does dementia with Lewy bodies impact people differently based on sex?
Clinicians at the Norman Fixel Institute for Neurological Diseases at UF Health explored the differences a person's sex makes when it comes to DLB diagnosis and management.
Clinicians at the Norman Fixel Institute for Neurological Diseases at UF Health explored the differences a person's sex makes when it comes to DLB diagnosis and management.
In a recent study, researchers at the Norman Fixel Institute for Neurological Diseases at UF Health and the University of Florida College of Pharmacy used Medicare data to compare the rate of hospitalizations and deaths between two common Parkinson’s disease medications: pimavanserin and quetiapine.
Team at the University of Florida receives renewal as a Research Center of Excellence by the Lewy Body Dementia Association for their commitment and care for Lewy Body dementias.
Dr. Melissa Armstrong wrote "Special Care Needs for Corticobasal Degeneration", a chapter in the World Alzheimer Report 2022.
Dr. Shannon Chiu awarded five-year grant from NIA to investigate changes in LBD using diffusion-weighted MRI and task-based EEG.
The Harry T. Mangurian Jr. Foundation supported grants for two Lewy body dementia pilot studies.
Dr. Melissa Armstrong co-authored a review in the journal Neurology discussing new FDA-approved drug.
Dr. Melissa Armstrong co-authored new guidance published in the journal Neurology.
Dr. Melissa Armstrong discusses thinking and memory challenges for Parkinson’s patients and research advances.
On Oct. 30 at 2pm, Dr. Melissa Armstrong will discuss Alzheimer's disease with a special focus on Lewy body dementia.